This leukopenia is transiently reversed in mice [41] and patients [42] upon inhibition of CXCR4 with the selective antagonist AMD3100 thus demonstrating the causal role of the gain-of-CXCR4 function. Here, CXCR4 is linked to Decreased total leukocyte count.